Comprehensive transcriptomics and proteome analysis to identify prognostic risk factors for MYCN non-amplified high-risk neuroblastoma

Abstract Background MYCN non-amplified (MYCN-NA) neuroblastoma (NB) demonstrates considerable heterogeneity in both biological and clinical aspects, and its molecular and biological characteristics remain inadequately defined. Methods A comprehensive multi-omics analysis was performed on transcripto...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Shan Liu, Zhihong Wang, Jianzhen Shen, Lizhi Li, Yaobin Lin
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2026-04-01
coleção:	Human Genomics
Assuntos:	High-risk neuroblastoma MYCN-NA Transcriptomics Proteomics Molecular targets
Acesso em linha:	https://doi.org/10.1186/s40246-026-00973-4
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!